Simulations Plus (NASDAQ:SLP) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Simulations Plus, Inc. (NASDAQ:SLP) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.59 and traded as high as $16.74. Simulations Plus shares last traded at $15.88, with a volume of 172,685 shares changing hands.

Analyst Upgrades and Downgrades

SLP has been the subject of several research reports. Weiss Ratings downgraded Simulations Plus from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st. Wall Street Zen raised Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Finally, TD Cowen dropped their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $24.40.

Simulations Plus Stock Down 4.6%

The firm has a market capitalization of $320.78 million, a price-to-earnings ratio of -5.07 and a beta of 1.33. The stock has a 50-day moving average price of $14.34 and a 200 day moving average price of $15.59.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The business had revenue of $24.29 million during the quarter, compared to the consensus estimate of $21.66 million. As a group, equities analysts forecast that Simulations Plus, Inc. will post 0.85 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Simulations Plus

Several institutional investors have recently added to or reduced their stakes in SLP. Raymond James Financial Inc. purchased a new stake in Simulations Plus during the second quarter worth approximately $25,000. Quarry LP purchased a new stake in Simulations Plus during the third quarter worth approximately $28,000. PNC Financial Services Group Inc. lifted its stake in Simulations Plus by 59.3% during the first quarter. PNC Financial Services Group Inc. now owns 4,485 shares of the technology company’s stock worth $53,000 after purchasing an additional 1,669 shares during the last quarter. Fifth Third Bancorp purchased a new stake in Simulations Plus during the first quarter worth approximately $54,000. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Simulations Plus by 343.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock worth $73,000 after purchasing an additional 3,084 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.